Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mpirik was a U.S.-based healthcare technology company focused on AI-enabled cardiology workflow and patient identification software for health systems. Its flagship Cardiac Intelligence platform reviewed EHR and diagnostic data to identify undiagnosed or undertreated cardiovascular patients, surface treatment gaps, and support automated care coordination and clinical research. The company emphasized cardiovascular screening at scale, including structural heart disease and rhythm-related conditions, and collaborated with health systems and medtech partners on care-improvement initiatives. Mpirik was acquired by Tempus in March 2023, and its cardiology software capabilities were positioned to be integrated into Tempus' broader AI-enabled precision medicine platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mpirik.